The Regulatory Affairs and Strategy team at Anavex Life Sciences plays a crucial role in guiding the development of therapeutics through regulatory processes, ensuring compliance with health authority requirements. This team is responsible for strategizing submission plans, managing interactions with regulatory agencies, and providing insights to align clinical development goals with regulatory expectations, thereby facilitating the advancement of innovative treatments for neurodevelopmental and neurodegenerative diseases.
Claus Van Der Velden
Director
Daniel Klamer
Vice President of Business Dev...
Daniel Klamer, PhD, ...
vice President, Business Devel...
David Goldberger
Senior Vice President Regulato...
Elliot Favus
Director
Emmanuel O Fadiran
Senior Vice President of Regul...
Nell Rebowe
Director of Business Developme...
Peter Donhauser
Director
Steffen Thomas
Director
Tom Skarpelos
Director